Safety considerations of recombinant protein therapy: Introductory comments

Clinical Immunology and Immunopathology

Volumn 83, Issue 1, 1997, Pages 1-4

  Hayes, Terence J ^a   Ryffel, Bernhard ^b  

^a HOFFMANN LA ROCHE INC   (United States)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ALTEPLASE; BETA INTERFERON; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 CONCENTRATE; BLOOD CLOTTING FACTOR 9; BLOOD CLOTTING FACTOR 9 CONCENTRATE; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HUMAN INSULIN; INSULIN; INTERFERON BETA SERINE; RECOMBINANT BLOOD CLOTTING FACTOR 8; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT GAMMA INTERFERON; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RECOMBINANT INTERLEUKIN 2; RECOMBINANT PROTEIN; SOMATREM;

CONFERENCE PAPER; DRUG SAFETY; DRUG TOXICITY; GOOD CLINICAL PRACTICE; HUMAN; IMMUNOTHERAPY; PRIORITY JOURNAL; SIDE EFFECT;

EID: 0031127953     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1996.4301     Document Type: Conference Paper

References (11)

1. 1. Aggarwal, B. B., and Puri, R. K., "Human Cytokines. Their Role in Disease and Therapy." Blackwell, Cambridge, 1995.
2. 2. Anderson, T. D., Arceco, R., and Hayes, T. J., Comparative toxicity and pathology associated with administration of recombinant HuIL-1 alpha to animals. Int. Rev. Exp. Pathol. 34(A), 9-36, 1993.
3. 3. Beutler, B., and Grau, G. E., Tumor necrosis factor in the pathogenesis of infectious diseases. Crit. Care Med. 21(Suppl. 10), S423-S435, 1993.
4. 4. Dexter, T. M., Garland, J. M., and Test, N. G., Colony stimulating factors: Molecular and cell biology. Dekker, New York, 1990.
5. 5. Hayes, T. J., and Cavagnaro, J. A., Progress and challenges in the preclinical assessment of cytokines. Toxicol. Lett. 64-65, 291-297, 1992.
6. 6. Kung, A. H., Cavagnaro, J. A., Makin, A., White, M. A., and Kong, K. N., Toxicologic evaluations of an immunotoxin, H65-RTA. Fundam. Appl. Toxicol. 26, 75-84, 1995.
7. 7. Metcalf, D., and Nicloa, N., The hemopoietic colony stimulating factors. Karger, Basel, 1995.
8. 8. Ryffel, B., Cytokine induced pathology. Int. Rev. Exp. Pathol. 34 A and B, 1993.
9. 9. Kammüller, M., and Ryffel, B., Extrapolation of experimental safety data to man: The interleukin-6 case. Clin. Immunol. Immunopathol. 83, 15-17, 1997.
10. 10. Ryffel, B., Interleukin-12: Role of interferon-γ in IL-12 adverse effects. Clin. Immunol. Immunopathol. 83, 18-20, 1997.
11. 11. Gunn, H., Immunogenicity of recombinant human interleukin-3. Clin. Immunol. Immunopathol. 83, 5-7, 1997.